Emelia J. Benjamin, MD, ScM
Emelia J. Benjamin, MD, ScM is a Professor of Medicine and Epidemiology at Boston University Schools of Medicine and Public Health, and a clinical cardiologist at Boston Medical Center, an urban safety-net hospital. She conducts research at the Framingham Heart Study (FHS) on the genetics, epidemiology, and prognosis of atrial fibrillation. She is Multi-Principal Investigator on grants related to the genetics of atrial fibrillation and PI of the Research Training and Education Core for the National Institutes of Health’s American Heart Association Tobacco Regulation and Addiction Center. She is the author of over 550 peer-reviewed original research, reviews, and scientific guidelines articles. Her funding and publication details are at: http://profiles.bu.edu/Emelia.Benjamin.
Dr. Benjamin is Assistant Provost for Faculty Development at Boston University Medical Campus, and Vice Chair for Faculty Development and Diversity in the Department of Medicine at Boston University School of Medicine, where she co-designed and co-leads the early, midcareer, under-represented minority, and women’s faculty leadership programs (http://www.bumc.bu.edu/facdev-medicine/). She has a profound commitment to mentoring the next generation of academic medical faculty member and has won institutional and 2 National American Heart Association awards for her mentoring.
An active American Heart Association (AHA) volunteer, she received the 2015 Paul Dudley White Award, the 2016 AHA Gold Heart Award, and the 2016 Population Research Prize. She Chairs the AHA’s Science and Clinical Education Lifelong Learning Committee and the Cardiovascular Epidemiology Committee on Statistics.
Dr. Benjamin received her AB at Harvard College, her MD at Case Western Reserve University, Cleveland, OH, her medical residency at Boston City Hospital, her cardiology fellowship at Boston University, her echocardiography fellowship at Brigham & Women’s Hospital, her cardiovascular epidemiology research fellowship at the Framingham Heart Study and her Master’s in Epidemiology at Harvard School of Public Health.
Ralph J. Damiano Jr., MD
Ralph J. Damiano Jr., MD, is the Evarts A. Graham Professor of Surgery and chief of the Division of Cardiothoracic Surgery at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis and vice-chairman of the Department of Surgery. Born in White Plains, N.Y., Damiano graduated from Dartmouth College Summa Cum Laude and Phi Beta Kappa, majoring in biology. Damiano received his medical degree from Duke University, where he was elected to Alpha Omega Alpha. He went on to complete both his general surgery and cardiothoracic surgery training at Duke University Medical Center. During this time, Damiano received a National Research Service Award from the NIH for his work on the surgical treatment of arrhythmias.
Damiano has been a pioneer in the area of minimally invasive cardiac surgery. His developmental work on robotically assisted microsurgery for coronary artery bypass grafting (CABG) earned him a Computer World Smithsonian Award in June of 1997.
Damiano performed the first robotically assisted CABG procedure in North America in December 1998. He completed the first prospective clinical trial in the world on robotically assisted CABG. Damiano also has been active in the surgical treatment of arrhythmias. His team at Washington University is world-renowned for its clinical and basic research on the surgical treatment of atrial fibrillation. His group has been continuously funded by the NIH for over 30 years in this area and they have developed the gold-standard surgical procedure, the Maze operation, which has been adopted around the world. Recently, his group has developed a less-invasive procedure for atrial fibrillation that is more widely applicable to patients with this arrhythmia. Dr. Damiano also is the PI of the Cardiothoracic Surgical Research Training Grant, one of only two training grants that have been awarded in the US for Cardiothoracic Surgery.
Thomas Deering, MD
Dr. Deering is currently the director of the Arrhythmia Center of Piedmont Heart Institute. He also serves as the Chief of the Cardiovascular Centers of Excellence and as Chief Quality officer for Piedmont Heart Institute. He holds the Mark E. Silverman, M.D. Educational Chair. He graduated summa cum laude from the Yale University School of Medicine and completed his medical and cardiac electrophysiology training at Yale and Tufts New England Medical Center. After serving as an assistant clinical professor of medicine at Yale he moved to Atlanta and joined the staff of Piedmont Hospital, where he has practiced since that time. Dr. Deering is board-certified in internal medicine, cardiology and clinical cardiac electrophysiology. He is a fellow of the American College of Cardiology, the American College of Physicians and the Heart Rhythm Society. He has served on multiple AHA committees, ACC committees and the NCDR ICD Registry Research &&Publication Committee. He has been most active as a member of the Heart Rhythm Society (HRS); has served on a number of HRS committees and task forces; presently sits on the Board of Trustees and serves as the President-Elect. Dr. Deering’s areas of research center upon how device-based diagnostic and therapeutic innovations can create clinical and quality improvement and the development of systemic management approaches for patients with atrial fibrillation. He is a reviewer for multiple cardiac and electrophysiology journals. His primary clinical area of interest is focused upon developing and improving guideline-driven, team-based oriented patient care programs aimed at producing high quality coordinated cardiovascular care across healthcare systems to create value for both patients and the healthcare system.
Luigi Di Biase, MD, PhD
Luigi Di Biase, MD, is Director of Arrhythmia Services, Section Head of Electrophysiology, and Associate Professor of Medicine (Cardiology) at Einstein/Montefiore. In addition, he serves as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas.
Improving patient care is the heart of Dr. Di Biase's mission. He believes that this is possible through dedicated clinical practice associated to cutting-edge clinical research. Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.
Dr. Di Biase, MD, PhD, FACC, FHRS, is a 2000 graduate (summa cum laude) of the medical school and a 2004 graduate (summa cum laude) of the cardiology residency program at the University of Bari, Bari, Italy. In 2006, he completed a second-level master degree in Electrophysiology and Pacing (summa cum laude) at the University of Insubria, Varese, Italy.
In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship under the supervision of Dr. Andrea Natale at the Miller Family Heart & Vascular Institute at the Cleveland Clinic, Cleveland, Ohio. The following year, he accepted a position in cardiac electrophysiology at the University of Texas Medical School Branch in Galveston, Texas, where he continued to focus on his research projects at St. David's Medical Center under the leadership of Dr. Natale.
Dr. Di Biase was appointed Assistant Professor in 2007 at the University of Foggia, Italy, where he completed the PhD program in cardiovascular physiopathology in November 2010.
In 2009, Dr. Di Biase was appointed Adjunct Assistant Professor at the University of Texas at Austin, where he was promoted to Adjunct Associate Professor in 2012, the same year he joined Albert Einstein College of Medicine and Montefiore Medical Center with the title of Associate Professor, Department of Medicine (Cardiology).
In September 2014 Dr. Di Biase was appointed Section Head of Electrophysiology and Director of Arrhythmia Services at Einstein/Montefiore, while continuing to serve as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center.
Dr. Di Biase is the author of about 250 publications in indexed journals, about 280 abstracts, and 14 electrophysiology book chapters. He has presented at numerous national and international conferences as an invited speaker.
Dr. Di Biase is a member of the Italian Federation of Cardiology and Electrophysiology (FIC-AIAC), the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), the American College of Cardiology (ACC), the American Heart Association (AHA), and a Fellow of the Heart Rhythm Society (FHRS), and the American College of Cardiology (FACC). He is also an honorary member of the Korean Society of Cardiology.
Dr Di Biase serves as reviewer of major electrophysiology and cardiology journals, and as an editorial board member of Heart Rhythm Journal, Heart Rhythm Journal Case Report, Journal of Cardiovascular Electrophysiology and Journal of Cardiovascular Medicine. He is Assistant Editor for Journal Interventional Cardiac Electrophysiology (JICE) and Associate Section Editor forPacing and Clinical Electrophysiology (PACE).
Christopher Ellis, MD
Dr. Ellis joined the faculty at Vanderbilt University in 2009 after completing his Cardiac Electrophysiology Fellowship at the University of Michigan. He has developed expertise in hybrid catheter and surgical AFib ablation as well as LAA closure. Vanderbilt Heart has been a pivotal site for the DEEP-AF trial, AMAZE trial, and Amulet versus Watchman trial, and the LAA Closure Program and Va-LAA Registry at Vanderbilt Heart has enrolled over 250 percutaneous LAA closure subjects. He recently published the sentinal LAA closure efficacy outcome data on the Atriclip device placed by thoracoscopic technique. Area of expertise: Atrial fibrillation, LAA and stroke, LAA closure technologies
Steve Hoff, MD
Steven J. Hoff, MD received his medical degree from The Johns Hopkins University School of Medicine in Baltimore. He completed his internship in general surgery, a research fellowship in cardiac surgery, and a residency in cardiac and thoracic surgery at Vanderbilt University Medical Center in Nashville, TN. He was in a private practice at St. Thomas Hospital in Nashville until 2007, when he joined the faculty at Vanderbilt. As an Associate Professor of Clinical Cardiac Surgery in the Department of Cardiac Surgery, Dr. Hoff served as the Surgical Director of the Vanderbilt Heart Center for Atrial Fibrillation and as the Associate Program Director for the Cardiothoracic Residency Training Program. In 2014 he joined Orlando Health Cardiovascular and Thoracic Surgery. He currently serves as Associate Professor of Surgery at the University of Central Florida School of medicine in Orlando. Dr. Hoff’s research interests including minimally invasive and hybrid approaches to treating coronary artery disease and atrial fibrillation. He has published over 40 articles and book chapters in peer-reviewed publications covering a range of subjects including minimally invasive mitral valve surgery, arrhythmia surgery, and hybrid coronary revascularization. Dr. Hoff is certified by the American Board of Thoracic Surgery. He is a fellow with the American College of Surgeons and the American College of Cardiology, and a member of The Society of Thoracic Surgeons, the Heart Rhythm Society, the International Society of Minimally Invasive Cardiac Surgery, and other professional organizations.
Jose (Pepe) Jalife, MD
Dr. Jalife completed his M.D. at the Universidad Nacional Autónoma de México in 1972. After clinical training in Spain, he trained as a postdoctoral fellow in the Masonic Medical Research Laboratory in Utica, NY. He joined the Department of Pharmacology, Upstate Medical University, as a member of the faculty in 1980 and became its Chairman in 1988. In January of 2008, he was recruited by the University of Michigan to his present position as Professor of Internal Medicine and the Cyrus and Jane Farrehi Professor of Cardiovascular Research and Professor of Molecular & Integrative Physiology. In 2014, he was recruited to the Spanish National Center for Cardiovascular Research in Madrid as a Group Leader in the Cardiac Arrhythmia Laboratory.
Dr. Jalife is a leader in the study of the fundamental mechanisms of atrial fibrillation, ventricular tachycardia/fibrillation and sudden cardiac death. He has published more than 350 original papers and review articles, and has edited/authored fifteen books, including the internationally acclaimed Cardiac Electrophysiology: From Cell to Bedside, now in its sixth edition. His awards include the Distinguished Scientist Award of the American College of Cardiology, the Distinguished Scientist Award of the Heart Rhythm Society, the Mirowski Award of Excellence in Cardiology and Electrophysiology and the Arthur C. Guyton Distinguished Lecturer award in Physiology. Dr. Jalife is a Fellow of the American Heart Association, Fellow of the Heart Rhythm Society and member of the Association the American Association of Physicians. In 2015 he was awarded a Doctor Honoris Causa by the University of Valencia in Spain.
Jacob Koruth, MD
Dr. Koruth is currently an Assistant Professor of Cardiology, Mount Sinai Medical Center, and Director of the Experimental Research Laboratory. He maintains a busy electrophysiology practice and actively manage complex cardiology / arrhythmia patients. His responsibilities include electrophysiology fellow’s education, performing procedures clinically as well as directing large animal based research that focusses primarily in the area of new technological application in electrophysiology.
Suneet Mittal, MD
Dr. Mittal earned his BA and MD degrees from Boston University as part of a combined 6-year BA-MD program. He did an internship and residency in Internal Medicine as well as a fellowship in Cardiovascular Diseases at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. He then completed a fellowship in Clinical Cardiac Electrophysiology at the New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Mittal is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.
He is currently the Director of the Electrophysiology Laboratory and Associate Chief of Cardiology at The Valley Hospital in Ridgewood, New Jersey.
Dr. Mittal’s active research interests include the evaluation and management of patients with atrial fibrillation, the role of the left atrial appendage in patients with persistent atrial fibrillation, the evaluation and management of patients with unexplained syncope, the role of implantable monitors in patients with known or suspected arrhythmias, and overcoming barriers to remote patient monitoring.
He serves as the Heart Rhythm Society’s Co-Ambassador to India. He is currently an Associate Editor for the Heart Rhythm Case Reports Journal and an Editorial Board member of Heart Rhythm and the Journal of Interventional Cardiovascular Electrophysiology.
Andrea Natale, MD, FHRS, FACC, FESC
Patients from around the world seek treatment from Dr. Natale. A world recognized leader in the field of electrophysiology, Dr. Natale is a dedicated clinician, academician and researcher.
Prior to the establishment of Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Dr. Natale was a member of the Cardiovascular Medicine Department at the Cleveland Clinic from 1999 to 2007, serving most recently as Section Head for the Department of Cardiac Pacing and Electrophysiology and as Medical Director for the Cleveland Clinic’s Center for Atrial Fibrillation. In 2006, Dr. Natale was named to the Food and Drug Administration’s Task Force on Atrial Fibrillation.
A committed academician, Dr. Natale’s faculty positions at a variety of prestigious universities include Duke University and Stanford University. He has been an invited lecturer at more than 200 symposiums and conferences around the world, and is the author or co-author of hundreds of published articles on pacing and electrophysiology. In addition to serving on the editorial boards of numerous medical journals, he is editor-in-chief of the Journal of Atrial Fibrillation.
Dr. Natale’s greatest reward is restoring his patients to a life free of cardiac arrhythmia. He pioneered a circumferential ultrasound vein-ablation system to correct atrial fibrillation and performed the procedure on the world’s first five patients. He also developed some of the current catheter-based cures for atrial fibrillation, and was the first electrophysiologist in the nation to perform percutaneous epicardial radiofrequency ablation, which is a treatment for people who fail conventional ablation. He also holds a patent for a device used to treat Atrial Fibrillation.
A forefront researcher, Dr. Natale focuses on innovative advances in the treatment of atrial fibrillation. His goal is to benefit patient care through technologies such as robotic devices and specialized ablation catheters.
Professor of Medicine
Director, Heart Rhythm Services
Mayo Clinic/St. Marys Campus
Douglas L. Packer, MD
Douglas L. Packer, MD, is a consultant in the Division of Cardiovascular Diseases, Department of Internal Medicine, at Mayo Clinic Rochester. He is the Director of the Heart Rhythm Services and the Director of the Translational Electrophysiology Research Laboratory. Dr. Packer is recognized with the academic rank of the John M. Nasseff, Sr., Professor in Cardiovascular Diseases, and is internationally known in cardiac electrophysiology.
He received the MD degree at the University of Utah and completed an internship, residency and fellowship at Duke University, where he was on staff before coming to Mayo. His honors and awards include the Distinguished Service Award from Brigham Young University.
Dr. Packer is active in the Heart Rhythm Society where he is a past president and member of the Board of Trustees. He is also active in the American Heart Association and the American College of Cardiology. He has served on editorial boards for the American Heart Journal, the Journal of Cardiovascular Electrophysiology, Heart Rhythm journal, and the Journal of the American College of Cardiology. He also has served on National Heart, Lung, and Blood Institute work groups on atrial fibrillation.
Dr. Packer has been an active teacher and mentor, and also lectures widely on cardiac arrhythmias. He has written or co-authored more than 280 publications. He has lectured extensively in national and international meetings, giving over 1,400 invited lectures in 37 countries. He has served on the executive committee of a number of NIH multicenter randomized clinical trials, Including the MUSTT, SCD-HeFT, and HAT Trials. Dr. Packer is also the International Principal Investigator of the recently funded NIH CABANA Pivotal Study. In this capacity he leads the consortium of centers directing the trial.
Dr. Packer is a Mayo Clinician Investigator. His translational work focuses on the mechanisms and ablation of atrial fibrillation and other cardiac arrhythmias, autologous fibroblast modulation of electrical impulse propagation in the heart, and the development of carbon particle catheter-free ablation of arrhythmias. His clinical work investigates 4/5 dimensional integrated image-guided ablation, and the development of new energy sources for the modification of cardiac tissue. His work has been funded in part by private foundations, the American Heart Association, and the NIH. Dr. Packer holds US and European patents in the development of intracardiac ultrasound and 4/5D imaging.
Eric N. Prystowsky, M.D.
Dr. Prystowsky is a practicing Cardiologist with St. Vincent Medical Group, and Director of the Clinical Electrophysiology Laboratory at St. Vincent Indianapolis Hospital. He is also a Consulting Professor of Medicine at Duke University Medical Center.
Dr. Prystowsky is a graduate of Pennsylvania State University and the Mt. Sinai School of Medicine. He completed his internal medicine training at Mt. Sinai Hospital, New York City, and his training in cardiology and clinical electrophysiology at Duke University Medical Center, Durham, North Carolina.
From 1979 to 1986, Dr. Prystowsky was a full-time faculty member at the Indiana University School of Medicine, where he was Director of the Electrophysiology Laboratory. In 1986, he returned to Duke University as Professor of Medicine and Director of the Cardiac Arrhythmia Center. He joined The Care Group in 1988. In addition to co-authoring two textbooks, Cardiac Arrhythmias: An Integrated Approach for the Clinician; and Clinical Electrophysiology Review, Dr. Prystowsky has also authored over 700 publications concerning cardiac arrhythmias. He is the Editor-in-Chief of The Journal of Cardiovascular Electrophysiology and is also on the editorial board of 16 journals, including Circulation.
Additionally, he is past chairman of the American Heart Association’s Committee on Electrocardiography and Electrophysiology, past president of the Heart Rhythm Society, and past chairman of the Test Writing Committee for Clinical Electrophysiology for the American Board of Internal Medicine. He was given the Distinguished Alumni Award from Pennsylvania State University in 2007.
Andrea M. Russo, MD Dr. Russo is Professor of Medicine at Cooper Medical School of Rowan University, Director of Electrophysiology and Arrhythmia Services and Director of the CCEP Fellowship Program at Cooper University Hospital in Camden, N.J. She previously joined the faculty at the University of Pennsylvania School of Medicine in Philadelphia, PA in 1997 and was Director of the Electrophysiology Laboratory at Penn Presbyterian Medical Center and Clinical Associate Professor of Medicine at the University of Pennsylvania School of Medicine. Dr. Russo is active on several national committees, sub-committees and work groups within the Heart Rhythm Society (HRS), American College of Cardiology (ACC) and the American Heart Association (AHA). She is the current 1st Vice President of HRS, Chair of the HRS Program Committee, member of the HRS Board of Trustees, member of the ACC Science and Quality Strategic Execution and Operations Leadership (SEOL) Subcommittee, member of the ACC Cardiovascular Disease in Women Committee, member of the ACC/AHA Task Force on Performance Measures, and member of the AHA Get with the Guidelines-Atrial Fibrillation Clinical Work Group. She is also the former Treasurer/Secretary of HRS, former Chair of the HRS Finance Committee, former Chair of the HRS Health Policy Committee, former Vice-Chair of the HRS Quality Improvement (QI) Subcommittee, former Chair of the ACC Best Practice and Quality Improvement (BPQI) Subcommittee, former Chair of the ACC Cardiovascular Practice Improvement Program, and former member of the American Board of Internal Medicine (ABIM) Subspecialty Cardiovascular Disease Test Writing Committee. Dr. Russo also served as a member of the National Quality Forum (NQF) Cardiovascular Measurement Endorsement and Maintenance Committee, in addition to several other volunteer efforts within HRS, ACC and AHA. She has also served as co-chair or member on several guideline or consensus document writing groups. Dr. Russo has authored or co-authored numerous peer-reviewed journal articles, abstracts and book chapters. Her areas of particular interest include gender differences in arrhythmias, implantable cardioverter defibrillators, atrial fibrillation, and performance improvement activities.
Ben Steinberg, MD
Dr. Steinberg is an Assistant Professor of Medicine at the University Of Utah School Of Medicine, Division of Cardiovascular Medicine, Clinical Cardiac Electrophysiology Section. He received his undergraduate degree magna cum laude from Cornell University and his medical degree from The Johns Hopkins University School of Medicine. Dr. Steinberg completed internal medicine residency on the Osler Medical Service at The Johns Hopkins Hospital and fellowships in cardiovascular disease, clinical research, and clinical cardiac electrophysiology at Duke University Hospital and the Duke Clinical Research Institute. At Duke, he also received a Master’s of Health Sciences in clinical research.
He is the managing editor of Critical Pathways in Cardiology, and has authored or co-authored numerous books, chapters, and peer-reviewed articles in leading cardiovascular journals such as Circulation, Journal of the American College of Cardiology, and Heart Rhythm. His primary research interests focus on personalizing treatments for patients with heart rhythm disorders, and he is board certified in Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology.
Professor of Medicine and Bioengineering (by courtesy)
Director, Cardiac Electrophysiology & Arrhythmia Service
Paul Wang, M.D.
Stanford University he Stanford Cardiac Arrhythmia Service and Professor of Medicine and of Bioengineering (by courtesy). He has co-authored textbooks on implantable defibrillators, sudden cardiac death, cardiac resynchronization/ biventricular pacing therapy, and innovations in arrhythmia therapy. Dr. Wang participates on numerous national boards and panels in cardiac electrophysiology. Dr. Wang has been selected as the Editor-in-Chief of one of the field’s most pre-eminent journals, Circulation: Arrhythmia and Electrophysiology. He is a member of the American Heart Association Council on Clinical Cardiology, a member of the American Heart Association Science and Clinical Education Lifelong Learning (SCILL) Committee, and past Chair of the American Heart Association Council on Clinical Cardiology ECG and Arrhythmias Committee and the past member of the American College of Cardiology Electrophysiology Committee. He helped found the American Heart Association Arrhythmia Research Summit at the AHA Annual Scientific Sessions. He was previously a member of the Cardiac Electrophysiology Board Certification Exam Writing Committee of the American Board of Internal Medicine. He was past Chair of the CME Compliance Subcommittee and Vice-Chair of the Education Committee of the Heart Rhythm Society. He was an Associate Editor of the Heart Rhythm Journal. He is a former member of the Board of Trustees of the Heart Rhythm Society. Dr. Wang is Co-Director of the Bioengineering Scholarly Concentration of the Stanford School of Medicine. Dr. Wang directs the course Bioengineering 390, Introduction to Bioengineering Research. Dr. Wang with Dr. Paul Yock organizes an annual meeting, “Stanford Biodesign New Arrhythmia Technologies Retreat”, focusing on new technological advances in arrhythmia management and diagnosis. Dr. Wang is a member of the Stanford Biodesign Center program committee and the Center’s Faculty Liaison.
Dr. Wang's research studies centers on the development of innovative approaches to the treatment of arrhythmias, including catheter ablation, implantable devices, and diagnostic techniques. Dr. Wang has invented a number of new arrhythmia technologies and has 17 issued patents. Dr. Wang is co-inventor of a cryoablation method and device that has been the basis of a cryoablation catheter which has been FDA approved (Cryocath, Inc. acquired by Medtronic, Inc.). Catheter cryoablation has been used in over 250,000 patients with atrial fibrillation and supraventricular tachycardias. Dr. Wang published the first report of balloon cryoablation in 2006.
More recently, Dr. Wang has invented and patented a catheter device that is designed to walk on the inner surface of the heart. Dr. Wang has developed algorithms to improve rhythm detection including a technique for T wave subtraction to identify the P wave morphology of atrial arrhythmias. Recently Dr. Wang coauthored a best practices guide for cryoablation of atrial fibrillation based on 3000 procedures. Dr. Wang recruited Dr. Sanjiv Narayan to be part of the Stanford faculty. Dr. Narayan is inventor and creator of Focal Impulse and Rotor Modulation (FIRM) mapping to guide atrial fibrillation ablation. Dr. Wang actively participates in FIRM related research and uses FIRM mapping regularly.
Randall Wolf, MD
Dr. Randall Wolf is a surgical innovator who pioneered a minimally invasive procedure for the surgical treatment of lone AF. He has performed over 1000 Wolf minimaze procedures and has demonstrated the procedure to over 600 heart surgeons worldwide. He has been visiting professor in 18 countries, including Oxford University, University of Tokyo and Peking University. Dr. Wolf has delivered hundreds of invited lectures at hospitals, academic meetings and seminars in the United States and abroad.
Dr. Wolf was the first North American heart surgeon to perform DaVinci cardiac surgery. He has served as Professor of Surgery, Ohio State University and Professor of Surgery and Biomedical Engineering, University of Cincinnati, and the inaugural Ethicon-Endosurgery Chair for Innovation in Surgery. He has over 100 peer reviewed papers and textbook chapters, and was the inaugural co-editor of the Innovations Journal. He has served as President of both the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) and the 21st Century Cardiothoracic Surgery Club. When not in the operating theatre or lecturing, he performs stage and close-up magic.
Richard Wu, MD
Cardiologist Richard Wu, MD is a nationally recognized expert in evaluating and treating cardiac arrhythmias (heart rhythm disorders) and has been at the forefront of using cardiac ablation procedures to treat these conditions for over 15 years. He serves as the Director of the Cardiac Electrophysiology (EP) Lab at the University of Texas Southwestern Medical Center at Dallas, where he is Professor of Internal Medicine and holds the Dallas Heart Ball Chair in Cardiac Arrhythmia Research and the L. David Hillis Professorship in Clinical Research in Cardiology. Dr. Wu earned both his undergraduate and medical degrees with honors at Duke University. He completed his internal medicine, cardiology, and EP fellowships at the Johns Hopkins Hospital. He began his career at the University of Oklahoma, learning from EP pioneer Warren “Sonny” Jackman, M.D., who was the first to cure patients with abnormal electrical pathways in the heart using novel mapping techniques to localize arrhythmias and perform minimally invasive catheter ablation. Since moving to Dallas, Dr. Wu has specialized in treating a broad range of patients – from young children to the elderly – with heart rhythm disorders. He has a particular interest in the management of atrial fibrillation, ventricular tachycardia, and arrhythmias in patients with congenital heart disease. Dr. Wu enjoys his role as professor mentoring young physicians in training, teaching them his specialty, and advancing the future of medicine. “Patients often come to us very sick, with a lot of symptoms and sometimes life-threating conditions. One of the most gratifying things about what I do is help people get back to the things in life they enjoy doing.”
Mellanie True Hills, CSP
Following a brush with death in emergency heart surgery, and a subsequent close call with a stroke due to atrial fibrillation, Mellanie True Hills vowed to help others avoid heart disease and stroke.
She founded the non-profit American Foundation for Women's Health and StopAfib.org, a patient advocacy organization that informs and supports those living with atrial fibrillation. She speaks out about heart disease, stroke, and patient advocacy at medical conferences, hospital atrial fibrillation and women's events, and corporate events.
From partnering in Facing AFib featuring actress Susan Lucci and the AF Stat coalition featuring NBA Hall-of-Famer Jerry West, to following Barry Manilow at the podium in front of members of Congress, atrial fibrillation and stroke awareness are real passions for Mellanie. Through StopAfib.org, the most visited arrhythmia site, she raises awareness of atrial fibrillation to decrease afib-related strokes, improves the quality of life of those living with afib, and enhances communication with health-care providers.
Successes include creating Atrial Fibrillation Awareness Month and lobbying with other organizations to gain US Senate designation of September as National Atrial Fibrillation Awareness Month. She brings the voice of the atrial fibrillation patient community to think tanks, health policy discussions in Washington, DC and awareness-raising coalitions and partnerships worldwide. She is the author of the multiple award-winning book, A Woman's Guide to Saving Her Own Life: The HEART Program for Health and Longevity, and two best-sellers, Intranet Business Strategies (© Wiley) and Intranet as Groupware (© Wiley). She is a regular contributor on patient perspectives to medical publications and has been featured by hundreds of media around the globe.
Eliz was seven-months pregnant with twins when she suffered a massive heart attack. Her life changed, not only did she survive a ten-minute cardiac arrest, the cesarean delivery of her daughters and open-heart surgery, all on the same day, she also gained new perspective and passion for life. In the years since her heart attack she has dedicated herself to protecting her heart health and to inspiring others to pay attention to their health. She advocates for advancement in treatment and technology. Her life was saved through the use of Beating Heart Bypass and she currently uses an implanted loop recorder to diagnose her arrhythmia.
Eliz’s humorous and energetic style makes her one of the top female motivational speakers and a dynamic hybrid event emcee. She built a successful business as a heart health speaker, journalist and author. Her articles and interviews have an international audience. Eliz’s facilitated mastermind sessions leverage her business and entrepreneurial insights and high level moderation skills. Whether it is a heart health program or an entertaining stress management keynote, Eliz gets participants on their feet, dancing, and sends them home ready to do something different!
The author of four books including the Busy Woman’s Guide to a Healthy Heart and a Top 50 Health and Wellness Blog, she was named a Top Ten Online Influencer on Stress. Eliz provides well-researched, down-to-earth tips and strategies to fit into an already busy day. She has been seen on CNN, TNT, Lifetime and The Doctors, and works with leaders and high performance teams to limit the impact of stress so they can increase productivity and feel better.
Debbe McCall spent three decades in a variety of healthcare settings, and most of her life decisively working to avoid the genetics and family history of so many other Americans. Her mother, most of her siblings and cousins had their first heart attacks before their 50th birthdays. Despite multiple lifestyle changes to change this pattern, she was diagnosed with atrial fibrillation shortly after her 50th birthday.
Today, she is an active leader in the heart disease community. From helping to lead online support communities, speaking engagements, to supporting cutting edge research, you will be hard pressed to find a space to better understand AFib without Debbe McCall helping to lead the charge. She is a moderator and leader of the the Atrial Fibrillation Support Forum, the first AF support group on Facebook. She has spoken about the patient experience for CardioSmart at ACC and HRS as well patient conferences for SADS,Health eVoices and StopAFib. She has also been interviewed many times about patient engagement and research, her experience with atrial fibrillation and attending medical conferences.
In 2010, she was nominated to be a Patient Representative (SGE) to the FDA’s Cardiovascular Drug and Device Advisory Committee, and has served on over 16 AdComms including drugs, devices, reclassifications and biologics. In 2013 she joined the Health eHeart Alliance as an Interim Steering Committee member leading its early development, and in March of 2015 was elected as their first Chair and Co-PI. She is also a co-author of "Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials" in Clinical Trials Journal. She is also on the Data Safety Monitoring Board (DSMB) of the ADAPTABLE Aspirin Trial, a patient lead on multiple funded grants and a patient peer reviewer for manuscripts. You will find her at many medical conferences tweeting to her forum and followers.
General Sessions Featuring Renowned Afib Experts
2 Lunches & 5 Breaks
Live Q&A Opportunities
$100 Discount on 2016 AF Patient Conference Livestream + Video Replay
Friday Evening Gala VIP Reception
General Sessions Featuring Renowned Afib Experts
2 Lunches & 5 Breaks
Live Q&A Opportunities
$100 Discount on 2016 AF Patient Conference Livestream + Video Replay